Fierce Pharma

APRIL 24, 2023

Apellis hits setback in ALS trial after pair of pegcetacoplan approvals fkansteiner Mon, 04/24/2023 - 10:56

275

275

Pharmaceutical Technology

APRIL 24, 2023

Traditional medicine refers to the knowledge, skills and practices that indigenous and different cultures use to maintain health, encompassing forms such as herbal medicine, Traditional Chinese Medicine (TCM) and acupuncture. While 80% of the world’s population practices some form of traditional medicine, according to the World Health Organization (WHO), the practice is regularly discredited due to a lack of scientific support and regulation as well as evidence of negative side effects with cert

Medicine 105

Medicine Side effects Healthcare Healthcare 105

Fierce Pharma

APRIL 24, 2023

After delays, bluebird's sickle cell gene therapy finally lands at the FDA's desk zbecker Mon, 04/24/2023 - 11:15

FDA 229

FDA 229

MedCity News

APRIL 24, 2023

Eli Lilly is selling to Amphastar Pharmaceuticals global rights to Baqsimi, an emergency treatment for severe hypoglycemia in diabetes patients. The deal come as Lilly turns its focus to novel medicines for diabetes and other indications.

Medicine 101

Medicine Pharmaceutical Patients Biopharma 101

Advertisement

Distribution

Fierce Pharma

APRIL 24, 2023

Johnson & Johnson's PARP combo nabs first global nod but faces tough fight against AZ, Merck's Lynparza aliu Mon, 04/24/2023 - 10:32

196

196

MedCity News

APRIL 24, 2023

A health system’s failure to offer patients with digital payment options could lead to slower collection times, create a disjointed patient financial experience, and result in decreased patient satisfaction and loyalty. At HIMSS23, Atrium Health’s vice president of revenue cycle management shared how his system integrated payment into its digital front door and gave pointers to hospitals looking to do the same.

Management 100

Management Leads Patients 100

MedCity News

APRIL 24, 2023

With more freight moving around the world than ever, combined with increased external circumstances causing supply chain disruptions, there’s never been such pressure on the success of temperature controlled logistics as there is now. MedCity News sat down with John Coleman, Business Unit Director at YSDS Life Science, to talk about the challenges of delivering temperature-sensitive goods and how to overcome them.

Transportation 98

Transportation FDA Medical Healthcare 98

Fierce Pharma

APRIL 24, 2023

After massive equity awards, Regeneron's top 2 execs collected smaller pay packages in 2022 kdunleavy Mon, 04/24/2023 - 10:00

130

130

MedCity News

APRIL 24, 2023

Eden Health will join Hint Health’s Hint Connect platform, which is a network of independent direct primary care clinics. Through the partnership, employees of Hint Connect’s employer customers will be able to choose whether they want to receive care from a local DPC provider in their area (either in-person or virtually) or a virtual provider through Eden Health.

Networking 97

Networking 97

Fierce Pharma

APRIL 24, 2023

Johnson & Johnson eyes $40B valuation for consumer health group Kenvue: WSJ kdunleavy Mon, 04/24/2023 - 14:36

130

130

Advertisement

Clinical trial data management is increasingly challenging as studies grow in complexity. Quickly accessing and analyzing study data is vital for assessing trial progress and patient safety. In this paper, we explore real-time data access and analysis for proactive study management. We investigate using adverse event (AE) data to monitor safety and discuss a clinical analytics platform that supports collaboration and data review workflows.

Safety

Pharmaceutical Technology

APRIL 24, 2023

The National Institute for Health and Care Excellence (NICE) has published a final draft guidance recommending the use of Darzalex (daratumumab) with bortezomib and dexamethasone (DVd) for adults with previously treated multiple myeloma. The draft guidance is open for feedback from consultees after which the document and its recommendations will be used to establish the organization’s guidance on the use of this combination regimen for patients in the UK’s National Health Services.

Management 98

Management Patients 98

European Pharmaceutical Review

APRIL 24, 2023

Included in this issue of European Pharmaceutical Review : FOREWORD New quality requirements for tobacco products David Elder, David P Elder Consultancy QA/QC MASS SPECTROMETRY The benefits of mass spectrometry for expediting biologics to patients Ian Anderson, Mostafa Zarei and Qifeng Zhang, Lonza IN-DEPTH FOCUS: Bioprocessing/Bioproduction Realising the potential of AAV gene therapies Rajiv Vaidya, Andelyn Biosciences What gene therapy manufacturers can gain from collaboration Neil Almstead,

Pharmaceutical 94

Pharmaceutical Engineering Consulting Manufacturing 94

Pharmaceutical Technology

APRIL 24, 2023

The Covid-19 pandemic pushed the healthcare industry toward rapid digitalisation, with the rise of telehealth, telepresence systems, remote diagnostics, predictive AI, and wearable technology now changing the way healthcare is delivered and improving patient outcomes. Emerging technologies such as AR and VR are becoming increasingly routine for professional training, surgical assistance, and treatment for psychological and neurological disorders.

Healthcare 95

Healthcare Healthcare Doctors Healthcare Provider 95

MedCity News

APRIL 24, 2023

A clinical trial for a Foghorn Therapeutics cancer drug is under a partial FDA hold after a patient in the early-stage study developed a cardiovascular complication. It’s the biotech’s second partial hold in the past year.

FDA 90

FDA Leads Patients Biopharma 90

Advertisement

Planning on running clinical trials in Japan? How can you reliably supply these studies? Discover Catalent’s clinical supply packaging facility in Shiga, Japan. Strategically located between Tokyo and Osaka, and one of largest in Japan, this 6,000 square meter facility offers comprehensive services including primary and secondary clinical packaging and labelling, comparator sourcing, cold chain storage, local and global distribution, local language support and white glove service to support stud

Distribution

European Pharmaceutical Review

APRIL 24, 2023

Realising the potential of AAV gene therapies Dr Rajiv Vaidya, Head of Manufacturing Science & Technology at Andelyn Biosciences, explores strategies for improving the scalability and cost‑effectiveness of AAV production while maintaining regulatory compliance. What gene therapy manufacturers can gain from collaboration Neil Almstead, Chief Technical Operations Officer at PTC Therapeutics, shares his view on why collaboration is key to streamlining manufacture of gene therapies.

Manufacturing 93

Manufacturing Pharmaceutical 93

MedCity News

APRIL 24, 2023

Mae’s services will be a covered benefit for Aetna Better Health Medicaid members through a new pilot program. These services include access to a culturally-competent doula and an engagement platform that provides weekly check-ins and tools to support maternal health.

90

90

Clarivate

APRIL 24, 2023

Major U.S. healthcare payers and providers are consolidating at a dizzying clip as they seek to gain market share, increase access to care and secure clinical control to improve health outcomes. These mergers feature both vertical integration – as was the case with CVS’ watershed acquisition of Aetna five years ago – and horizontal integration, as with Elevance’s recent acquisition of Blue Cross Blue Shield of Louisiana.

Healthcare 89

Healthcare Healthcare Marketing Physicians 89

MedCity News

APRIL 24, 2023

A shift from fee-for-service payment models to value-based models is not an effective way to address the severe financial pressures that safety net hospitals are facing, experts argued at the HIMSS conference in Chicago. One called for a paradigmatic shift “away from cost savings and toward understanding where investments are needed.

Safety 88

Safety 88

Advertisement

Clinical research has entered a new era, one that requires real-time analytics and visualization to allow trial leaders to work collaboratively and to develop, at the click of a mouse, deep insights that enable proactive study management. Learn how Revvity Signals helps drug developers deliver clinical trial data insights in real-time using a fast and flexible data and analytics platform to empower data-driven decision-making.

Safety

European Pharmaceutical Review

APRIL 24, 2023

Included in this Guide to Testing: Exploring low endotoxin recovery in drug products Chiara Celli, Marco Mingolla and Fabrizio Lecce from the Institute of Biomedical Research Antoine Marxer, discuss low endotoxin recovery in drug products analysed using the monocyte activation test. Sustainability in BET from your endotoxin experts Associates of Cape Cod International, Inc. explores the future of sustainable LAL testing.

Pharmaceutical 85

Pharmaceutical 85

PharmaVoice

APRIL 24, 2023

Two decades after the Human Genome Project, scientists are on the brink of uncovering its full potential for drug development.

98

98

MedCity News

APRIL 24, 2023

DexCare is sponsoring a webinar May 19 highlighting how it’s taking lessons learned from online retailers to boost traffic and applies them to their healthcare customers. To learn more, register today.

Healthcare 77

Healthcare Healthcare Retail Patients 77

PharmExec

APRIL 24, 2023

Cost Plus Drug Co. adds J&J's Janssen medications to its offerings, increasing affordability for diabetes patients.

Medical 98

Medical Patients 98

Advertisement

When selecting a clinical supply provider, consideration often focuses upon the manufacturing, packaging, storage and distribution capabilities available that will, at face-value, be sufficient to meet the needs of the sponsor and their trial. However, there are human-based and knowledge-driven factors that are often overlooked that go beyond these basic physical capabilities and are integral to the development and delivery of high performing clinical supply chains.

Specialization

PharmaVoice

APRIL 24, 2023

Dr. Preeti Parikh sees parallels between promoting health equity and current DE&I challenges in the workplace.

98

98

Impetus Digital

APRIL 24, 2023

Register for one of Impetus’ upcoming webinars between May 23 – 29: How , Why , and What of Virtual Brand Planning About the webinars In this intimate learning session tailored exclusively to Pharma leaders, our expert speakers will share their best practices and tips on how to o ptimize internal brand planning meetings and other external KOL engagement and product launch initiatives (saving you money, time, and resources in the process).

Professional Services 73

Professional Services Education Healthcare Provider Consulting 73

Pharmatutor

APRIL 24, 2023

Skinimalism admin Mon, 04/24/2023 - 16:19 Vinay Kumar Singh. Head-Formulation Kumar Organic Products Research Centre Pvt. Ltd., Bengaluru Email : formulation_krc@kopresearchcentre.

71

71

MedReps

APRIL 24, 2023

Medical sales can be a tricky industry to get into. Your odds of obtaining a job rise considerably when you spend some time on the job, shadowing someone who already works as a sales rep. This not only gives you a good picture of what the job entails day in and day out, but it also can provide you with the experience and connections you need to get a job of your own in the industry.

Medical sales reps 66

Medical sales reps Medical sales Medical Sales 66

Advertisement

Clinical development organizations face a wide array of challenges when it comes to data, many of which can impact the operational effectiveness of their clinical trials. In this whitepaper, experts from Revvity Signals explore how solutions like TIBCO® Spotfire® enable better, more streamlined studies. The whitepaper also features a success story from Ambrx, a leading biopharmaceutical company, detailing how it has leveraged Spotfire to tackle data quality and collaboration challenges in clinic

Leads

Pharmaceutical Technology

APRIL 24, 2023

Vallon Pharmaceuticals has concluded the previously announced merger of its operations with biotechnology firm GRI Bio. With work on the agreement, announced in December 2022 , now complete, the combined entity will operate under the brand of GRI Bio. It will support the further development of GRI Bio’s natural killer T (NKT) cell modulators pipeline, to treat inflammatory, fibrotic and autoimmune diseases.

Pharmaceutical 64

Pharmaceutical Marketing 64

Copyright Clearance Center

APRIL 24, 2023

The post SSP’s Generations Fund Exceeds Halfway Point appeared first on Copyright Clearance Center.

89

89

PharmaTimes

APRIL 24, 2023

MDG1011 is a therapy which aims to improve outcomes for in patients with high-risk blood cancers

Patients 87

Patients 87

Copyright Clearance Center

APRIL 24, 2023

The post Dollars or Democracy? appeared first on Copyright Clearance Center.

98

98

Advertisement

As the development pipeline for new drugs continues to grow, biopharmaceutical companies are re-evaluating how to best manage and balance resources across an increasing number of development projects and complex clinical trials. There are two approaches that can be used to speed a drug from development to clinic faster: timeline compression and parallel processing, but only one that considers the benefits of integrating clinical supply into the overall drug development process.

Management